Epilepsy Clinical Trials in Durham, North Carolina

4 studies are recruiting for epilepsy in Durham, North Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Diagnosing Epilepsy To EffeCT Change

    The purpose of this research is to address the challenges of diagnosing and long-term management of epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. This resear…

    Stage
    Not phased
    Ages
    18 to 75
    Site
    Duke University, Durham, North Carolina
    Locations
    21 in total
    Run by
    Epiminder America, Inc.

    See if you can join NCT07110337 on ClinicalTrials.gov

  2. Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

    The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. Thi…

    Stage
    Not phased
    Ages
    18 to 75
    Site
    Duke University, Durham, North Carolina
    Locations
    18 in total
    Run by
    Epiminder America, Inc.

    See if you can join NCT07110454 on ClinicalTrials.gov

  3. A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures

    The purpose of the study is to evaluate the long-term safety and tolerability of brivaracetam.

    Stage
    Phase 3
    Ages
    0 and older
    Site
    Ep0156 237, Durham, North Carolina
    Locations
    36 in total
    Run by
    UCB Biopharma SRL

    See if you can join NCT04715646 on ClinicalTrials.gov

  4. Lemborexant Treatment of Insomnia Linked to Epilepsy

    The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Duke University, Durham, North Carolina
    Locations
    2 in total
    Run by
    University of Manitoba

    See if you can join NCT06262594 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.